» Articles » PMID: 25851811

Cyst Infection in Autosomal Dominant Polycystic Kidney Disease: Causative Microorganisms and Susceptibility to Lipid-soluble Antibiotics

Overview
Publisher Springer
Date 2015 Apr 9
PMID 25851811
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Cyst infection is a frequent and serious complication of autosomal dominant polycystic kidney disease (ADPKD). Lipid-soluble antibiotics like fluoroquinolones show good penetration into cysts and are recommended for cyst infection, but causative microorganisms are often resistant to these agents. This study investigated the profile of the microorganisms causing cyst infection in ADPKD, their susceptibility to lipid-soluble antibiotics, and clinical outcomes. This retrospective study reviewed all ADPKD patients admitted to Toranomon Hospital with a diagnosis of cyst infection from January 2004 to March 2014. All patients who underwent cyst drainage and had positive cyst fluid cultures were enrolled. Patients with positive blood cultures who satisfied our criteria for cyst infection or probable infection were also enrolled. There were 99 episodes with positive cyst fluid cultures and 93 episodes with positive blood cultures. The majority of patients were on dialysis. The death rate was high when infection was caused by multiple microorganisms or when there were multiple infected cysts. Gram-negative bacteria accounted for 74-79 % of the isolates in all groups, except for patients with positive hepatic cyst fluid cultures. The susceptibility of Escherichia coli to fluoroquinolones was very low in patients with hepatic cyst infection, especially those with frequent episodes and those with hepatomegaly. Fungi were detected in two episodes. Fluoroquinolone-resistant microorganisms showed a high prevalence in cyst infection. It is important to identify causative microorganisms to avoid the overuse of fluoroquinolones and to improve the outcome of cyst infection in ADPKD.

Citing Articles

Liver cyst penetration of antibiotics at the target site of infection: a randomized pharmacokinetic trial.

Bernts L, Bruggemann R, Jansen A, Jager N, Wertheim H, Drenth J J Antimicrob Chemother. 2024; 80(1):182-191.

PMID: 39508371 PMC: 11695873. DOI: 10.1093/jac/dkae394.


Polycystic intrahepatic infection caused by Enterococcus casseliflavus: a case report and literature review.

Xu S, Huang B, Cao Y, Zhong Z, Yin J BMC Nephrol. 2024; 25(1):88.

PMID: 38448824 PMC: 10919048. DOI: 10.1186/s12882-024-03531-z.


Autopsy of a 45-year-old Man with Liver Failure Due to Polycystic Liver Disease.

Mizuta M, Sekine A, Suwabe T, Hoshino J, Yamanouchi M, Mizuno H Intern Med. 2024; 63(21):2965-2970.

PMID: 38296484 PMC: 11604375. DOI: 10.2169/internalmedicine.2485-23.


A Unique Presentation of an Infected Renal Cyst: A Case Report and Literature Review.

Mansour P, Ammar L, O Gomez Urena E, Chow A, El Labban M Cureus. 2023; 15(10):e47966.

PMID: 38034202 PMC: 10685050. DOI: 10.7759/cureus.47966.


Fatal acute portal vein thrombosis associated with hepatic cysts in a patient with autosomal dominant polycystic kidney disease.

Tsuchida Y, Tsubata Y, Nozawa R, Maruyama S, Ikarashi K, Saito N CEN Case Rep. 2023; 13(1):32-36.

PMID: 37162720 PMC: 10834907. DOI: 10.1007/s13730-023-00795-6.


References
1.
Schwab S, Hinthorn D, DIEDERICH D, CUPPAGE F, Grantham J . PH-dependent accumulation of clindamycin in a polycystic kidney. Am J Kidney Dis. 1983; 3(1):63-6. DOI: 10.1016/s0272-6386(83)80012-2. View

2.
Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H . Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). Int J Antimicrob Agents. 2011; 37(3):210-8. DOI: 10.1016/j.ijantimicag.2010.10.032. View

3.
Schwab S, WEAVER M . Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. Am J Kidney Dis. 1986; 7(5):434-8. DOI: 10.1016/s0272-6386(86)80094-4. View

4.
Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K . Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease. Nephron Clin Pract. 2009; 112(3):c157-63. DOI: 10.1159/000214211. View

5.
Sallee M, Rafat C, Zahar J, Paulmier B, Grunfeld J, Knebelmann B . Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009; 4(7):1183-9. PMC: 2709515. DOI: 10.2215/CJN.01870309. View